Connor, Clark & Lunn Investment Management (CC&L)’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-246,681
| Closed | -$528K | – | 1406 |
|
|
2024
Q4 | $528K | Sell |
246,681
-37,472
| -13% | -$80.2K | ﹤0.01% | 1129 |
|
|
2024
Q3 | $1.24M | Sell |
284,153
-2,693
| -0.9% | -$11.7K | 0.01% | 815 |
|
|
2024
Q2 | $1.34M | Sell |
286,846
-27,656
| -9% | -$129K | 0.01% | 778 |
|
|
2024
Q1 | $1.59M | Buy |
+314,502
| New | +$1.59M | 0.01% | 735 |
|
|
2022
Q4 | – | Sell |
-82,881
| Closed | -$140K | – | 1210 |
|
|
2022
Q3 | $140K | Buy |
82,881
+70,551
| +572% | +$119K | ﹤0.01% | 1025 |
|
|
2022
Q2 | $30K | Buy |
+12,330
| New | +$30K | ﹤0.01% | 1015 |
|